SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $961,353 | -71.8% | 41,581 | -68.0% | 0.27% | -77.3% |
Q2 2023 | $3,408,600 | -31.7% | 130,000 | -25.7% | 1.19% | -14.6% |
Q3 2022 | $4,993,000 | -78.3% | 175,000 | -57.0% | 1.39% | -62.1% |
Q1 2022 | $22,971,000 | +24.1% | 407,000 | +36.3% | 3.68% | -45.3% |
Q4 2021 | $18,504,000 | +131.5% | 298,545 | +136.9% | 6.72% | +232.8% |
Q3 2021 | $7,994,000 | +288.1% | 126,013 | +404.1% | 2.02% | +173.9% |
Q2 2021 | $2,060,000 | +3.7% | 25,000 | -7.4% | 0.74% | +9.3% |
Q1 2021 | $1,986,000 | – | 27,000 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |